Is Shockwave Medical (SWAV) a Buy?
Analysts rate Shockwave Medical (SWAV) as a "Moderate Buy," with a 12-month price target of $248.00, indicating a potential 39.18% upside, making it an appealing option for growth-focused investors in the healthcare sector.
by Kowsalya
Updated Nov 08, 2023
Article continues below advertisement
On This Page
Is Shockwave Medical (SWAV) a Buy?
Shockwave Medical (SWAV) is favorably rated as a "Moderate Buy" by analysts, indicating a positive outlook on the stock. The consensus 12-month price target of $248.00 suggests a potential upside of around 39.18%, making it an attractive choice for investors seeking growth opportunities. SWAV's strong sales and earnings forecasts further underscore its potential within the healthcare sector.
Shockwave Medical (SWAV) Analysis
On November 11, 2023, Shockwave Medical Inc. (SWAV) closed at $178.19, marking a decrease of 17.08% compared to the previous day's closing price. The stock displayed a day's range between a high of $215.69 and a low of $184.83.
After-hours trading saw SWAV at $181.00, showing a positive uptick following the market close. The 52-week high and low values for SWAV were $240 and $170, respectively, reflecting its price volatility over the past year. With a market capitalization of $7.898 billion and a price-to-earnings (P/E) ratio of 26.79, Shockwave Medical continues to be a notable player in the healthcare and medical devices sector, despite the recent fluctuations in its stock value.
Shockwave Medical (SWAV)-Key Data
|
Data |
Value |
|
Closing Price |
$178.19 |
|
Change Percentage |
-17.08% |
|
Close Date |
Nov 07, 2023 |
|
52-Week High |
$240 |
|
52-Week Low |
$170 |
|
After-Hours Price |
$181.00 |
|
Market Capitalization |
$7.898B |
|
P/E Ratio |
26.79 |
|
RSI (14) |
34 |
|
Average True Range (14) |
$10.73 (6.02%) |
|
Beta |
1.01 |
|
Dividend Rate |
N/A |
|
Next Dividend Date |
N/A |
|
Stop-Loss |
N/A |
|
Overall Risk |
Lowest Low Medium High Highest |
|
Score |
-4.79 |
Shockwave Medical (SWAV)
Shockwave Medical (SWAV) is a renowned medical device company that specializes in innovative therapies to address cardiovascular and arterial diseases. Founded in 2009 and headquartered in Santa Clara, California, Shockwave Medical has gained prominence for its groundbreaking technology designed to enhance patient outcomes and improve the management of complex cardiovascular conditions.
Related Articles
Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.